Status:
NOT_YET_RECRUITING
ROLE OF PROPHYLACTIC TRANEXAMIC ACID IN PREVENTION OF POST-PARTUM HEMORRHAGE IN ELLSCS
Lead Sponsor:
Patel Hospital, Pakistan
Conditions:
Post Partum Hemorrhage
Eligibility:
FEMALE
18-45 years
Phase:
PHASE1
Brief Summary
IN THIS STUDY WOMEN UNDER GOING ELLSCS WOULD BE DIVIDED INTO TWO GROUPS , ONE GROUP WOULD BE GIVEN TRANEXAMIC ACID WHILE THE OTHER WOULD BE GETTING PLACEBO PROPHYLACTICALLY TO SEE THE EFFECT OF TRANEX...
Eligibility Criteria
Inclusion
- Pregnant women with singleton pregnancy and low risk for PPH admitted for ELLSCS
Exclusion
- Women with medical disorder or complex pregnancy.
- Women with history of PPH.
- Women with bleeding disorder.
- Abnormal placentation (MAP, placenta previa)
- Multiple pregnancy.
Key Trial Info
Start Date :
June 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT07002749
Start Date
June 1 2025
End Date
December 31 2025
Last Update
June 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Patel Hospital
Karachi, Sindh, Pakistan